SCHEMBL907793

SCHEMBL907793

CNC1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521237 1.00
SCHEMBL6519431 1.00
SCHEMBL6669388 0.97
SCHEMBL6670552 0.97 CYP2D6 (0.33)
SCHEMBL908114 0.92
SCHEMBL907881 0.92
SCHEMBL907792 0.92
Hydrochloric Acid SCHEMBL29202619 0.90
Hydrochloric Acid SCHEMBL27906334 0.90
SCHEMBL31094929 0.78 CYP2D6 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112778288-B Near-infrared solid-state light-emitting fluorescent probe and preparation method and application thereof 湖南大学 2022-08-09 CN claimed
CN-112778288-A Near-infrared solid-state light-emitting fluorescent probe and preparation method and application thereof 湖南大学 2021-05-11 CN claimed
CN-118574867-A Resin, molded article, optical material, lens, 2, 5-bis (isocyanatomethyl) furan, and polymerizable composition 三井化学株式会社 2024-08-30 CN disclosed
WO-2023183613-A2 INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR INFLAMMATION TACTOGEN INC (US) 2023-09-28 WO disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed
CN-112778288-B Near-infrared solid-state light-emitting fluorescent probe and preparation method and application thereof 湖南大学 2022-08-09 CN disclosed
US-20220144759-A1 COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-12 US disclosed
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
WO-2021178920-A1 COMPOUNDS FOR TARGETED DEGRADATION OF BRD9 C4 THERAPEUTICS, INC. (US) 2021-09-10 WO disclosed
EP-3458584-B1 FUSION PROTEINS COMPRISING AN ALDOLASE ENZYME JOINED TO A MALTOSE BINDING PROTEIN CONSEJO SUPERIOR INVESTIGACION (ES) 2021-07-07 EP disclosed
CN-112778288-A Near-infrared solid-state light-emitting fluorescent probe and preparation method and application thereof 湖南大学 2021-05-11 CN disclosed
EP-1983995-A2 NOVEL COMPOUNDS SmithKline Beecham Corporation (US) 2008-10-29 EP disclosed
CN-101212903-A Polycyclic carbamoylpyridone derivatives having HIV integrase inhibitory activity SMITHKLINE BEECHAM CORP (US) 2008-07-02 CN disclosed
WO-2007098393-A2 COMPOUNDS AND METHODS FOR TREATING DISEASES WITH TRPV4 CHANNEL RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2007-08-30 WO disclosed
CN-1980929-A 4-substituted piperidine derivatives BIOAXONE THERAPEUTIQUE INC (CA) 2007-06-13 CN disclosed
EP-0409894-A4 PLATINUM-AMINE-SULFOXIDES AS ANTI-TUMOR AGENTS 1992-12-02 EP disclosed
US-5028726-A Antitumor agents, chemotherapy THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 1991-07-02 US disclosed
EP-0409894-A1 PLATINUM-AMINE-SULFOXIDES AS ANTI-TUMOR AGENTS THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 1991-01-30 EP disclosed
WO-1989009598-A1 PLATINUM-AMINE-SULFOXIDES AS ANTI-TUMOR AGENTS THE UNIVERSITY OF VERMONT AND STATE AGRICULTURAL C (US) 1989-10-19 WO disclosed
US-4485020-A FLOW CONTROL AGENTS FOR ENHANCED OIL RECOVERY PHILLIPS PETROLEUM COMPANY (US) 1984-11-27 US disclosed